Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2020-01-31 | Reverse | 1:30 |
Myomo, Inc. develops myoelectric orthotics like the MyoPro to assist individuals with neuromuscular disorders in improving arm function, serving healthcare providers and patients nationwide.

The MyoPro 2x is an advanced powered orthosis that uses EMG signals to help individuals with upper-limb paralysis regain movement, featuring improved ease of use, fit, and functionality for daily activities.
| Icon | PRODUCT | Q2-2024 | Q3-2024 | Q4-2024 | Q1-2025 |
|---|---|---|---|---|---|
![]() | Product | $7.52M | $9.21M ▲ | $19.59M ▲ | $9.83M ▼ |
Overall rating: C
| PEER | PRICE | |
|---|---|---|
ECOR | $9.63 | COMPARE |
HYPD | $3.26 | COMPARE |
POCI | $4.40 | COMPARE |
MIRA | $0.75 | COMPARE |
NMTC | $1.77 | COMPARE |
MODD | $3.46 | COMPARE |
NXL | $0.25 | COMPARE |
RBOT | $0.04 | COMPARE |